CEO: Michael W. Hunkapiller

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Key numbers

Market Capitalization:594097350
Shares Outstanding: 154311000
Float: 141813661
Next Earning Date:2020-08-03
TTm EPS: -0.3437
TTm Dividend Rate:
200 days moving average:4.13
50 days moving average: 3.74
One day percent Change: -1.06

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,